Rheumatology clinical research is expanding significantly through a new strategic partnership between FOMAT and Arthritis & Rheumatology Centers, led by Dr. Tony Makhlouf. This collaboration represents a major advancement in FOMAT’s mission to provide sponsors and CROs with specialized research capabilities across critical therapeutic areas. With multiple clinics across Ventura County, Arthritis & Rheumatology Centers brings deep expertise in treating conditions such as rheumatoid arthritis, lupus, osteoarthritis, gout, and psoriatic arthritis.<\/p>\n
For FOMAT, this partnership aligns directly with its commitment to innovation in clinical research and to providing a robust platform for sponsors advancing treatments in specialized fields. Rheumatology encompasses a wide range of diseases affecting the joints, muscles, and connective tissues \u2014 conditions that require specific clinical knowledge and dedicated research approaches that generalist sites simply cannot replicate.<\/p>\n
Nicholas Focil, CEO of FOMAT, expressed strong enthusiasm for the collaboration: “We are thrilled to join forces with Arthritis & Rheumatology Centers. This collaboration demonstrates our commitment to driving innovation in rheumatology clinical research and providing sponsors with a comprehensive platform to advance their therapies in this critical therapeutic area. Together, we can make substantial progress in improving the lives of patients affected by Rheumatologic diseases while continuing to move the needle on diversity in clinical trials.”<\/p>\n
Arthritis & Rheumatology Centers, under Dr. Makhlouf’s leadership, has a longstanding history of providing exceptional care to patients with complex Rheumatologic diseases. Dr. Makhlouf brings invaluable experience in autoimmune diseases, chronic pain management, and inflammatory conditions \u2014 expertise that allows FOMAT to tap into a niche market where deep clinical understanding is essential for trial success.<\/p>\n
Dr. Makhlouf shared his perspective on the partnership: “Partnering with FOMAT provides a tremendous opportunity to combine our Rheumatology expertise with their extensive research site network. By working together, we can accelerate the development of novel therapies and make a significant impact in treating and managing Rheumatologic diseases. This collaboration underscores our shared commitment to advancing patient care and contributing to the field of Rheumatology.”<\/p>\n
Through this partnership, FOMAT and Arthritis & Rheumatology Centers will conduct comprehensive rheumatology clinical research trials covering the full spectrum of Rheumatologic conditions. These trials are critical for developing new therapies that can meaningfully improve quality of life, particularly for patients managing chronic and often debilitating conditions.<\/p>\n
For industry sponsors, this collaboration offers a streamlined platform to access a wide range of Rheumatologic conditions within a proven research infrastructure. By working with FOMAT, sponsors can leverage a network that spans multiple locations and provides access to diverse patient populations \u2014 a key advantage for understanding how therapies perform across different demographics and health profiles.<\/p>\n
The combination of FOMAT’s operational capabilities and Arthritis & Rheumatology Centers’ clinical depth gives sponsors the insights needed to accelerate development timelines and improve trial quality in rheumatology clinical research. This is an ideal partnership for organizations looking to make meaningful progress in one of the fastest growing therapeutic areas in drug development.<\/p>\n
Patients with Rheumatologic diseases gain direct access to clinical trials offering cutting edge treatments and the potential for better disease management. By expanding into rheumatology clinical research, FOMAT ensures that individuals suffering from these conditions have access to innovative therapies that might not otherwise be available locally.<\/p>\n
This partnership exemplifies both organizations’ dedication to improving patient outcomes. According to the Mayo Clinic<\/a>, conditions like rheumatoid arthritis affect quality of life significantly \u2014 making access to new treatments through clinical trials an important option for many patients.<\/p>\n The collaboration between FOMAT and Arthritis & Rheumatology Centers sets a strong precedent for how partnerships can bring together specialized clinical expertise and established research infrastructure to accelerate the development of life changing therapies. As the field of rheumatology clinical research continues to evolve, partnerships like this will play an essential role in ensuring that new treatments are both effective and accessible to those who need them most.<\/p>\n Read the full press release: FOMAT Partners With Arthritis & Rheumatology Center Led by Dr. Tony Makhlouf<\/a>.<\/p>\n To learn more about FOMAT’s growing network and research capabilities, visit our Physician Investigator Network<\/a> page or explore our Active Studies<\/a> to find current opportunities near you.<\/p>\n","protected":false},"excerpt":{"rendered":" Rheumatology Clinical Research: FOMAT Partners With Arthritis & Rheumatology Centers Rheumatology clinical research is expanding significantly through a new strategic partnership between FOMAT and Arthritis & Rheumatology Centers, led by Dr. Tony Makhlouf. This collaboration represents a major advancement in FOMAT’s…<\/p>","protected":false},"author":3,"featured_media":87671,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[901],"tags":[918,966,967],"class_list":["post-48366","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-updates","tag-clinical-research","tag-rheumatology","tag-trials-in-california"],"acf":[],"_links":{"self":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/posts\/48366","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/comments?post=48366"}],"version-history":[{"count":3,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/posts\/48366\/revisions"}],"predecessor-version":[{"id":87673,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/posts\/48366\/revisions\/87673"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/media\/87671"}],"wp:attachment":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/media?parent=48366"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/categories?post=48366"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/tags?post=48366"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}A Shared Vision for the Future of Rheumatology Research<\/h3>\n